By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Life Care NewsLife Care NewsLife Care News
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
Search
Technology
  • Advertise
  • Advertise
Health
Entertainment
  • Home
  • Business
    • Business
  • News
  • Tech
  • Entertainment
  • Health
  • Education
  • Automobile
  • Sports
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved.
LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Reading: Australia Delivers Certainty for US Biotechs in 2025:Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates
Share
Notification Show More
Font ResizerAa
Life Care NewsLife Care News
Font ResizerAa
  • Education
  • Automobile
  • Entertainment
  • News
  • Tech
  • Sports
Search
  • Home
  • Home
    • Home 1
    • Default Home 5
  • Categories
  • Categories
    • Tech
    • Entertainment
    • Automobile
    • Sports
    • Education
    • News
    • Health
  • Bookmarks
  • Bookmarks
  • More Foxiz
    • Sitemap
  • More Foxiz
    • Sitemap
Follow US
  • Advertise
  • Advertise
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Health

Australia Delivers Certainty for US Biotechs in 2025:Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates

GlobeNews Wire
Last updated: 26/05/2025 8:57 PM
GlobeNews Wire
Share
4 Min Read
Australia Delivers Certainty for US Biotechs in 2025:Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates
SHARE
Australia Delivers Certainty for US Biotechs in 2025:Avance Clinical Offers Fast Start-Up, Regulatory Predictability, and R&D Rebates

ADELAIDE, Australia, May 26, 2025 (GLOBE NEWSWIRE) — As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.

“In today’s capital-constrained biotech environment, sponsors need solutions that deliver speed, predictability, quality, and capital efficiency,” said Ben Edwards, Chief Operating Officer at Avance Clinical. “Australia is a smart strategic choice — it allows biotechs to start faster, control costs, reduce burn rate, and generate FDA-accepted data without the delays and complexity of the US IND process in a Phase I setting.”

Through its GlobalReady program, Avance Clinical enables biotech sponsors to rapidly initiate early phase trials in Australia — often within 5 to 6 weeks — without the need for an open IND. The company’s deep regulatory and scientific expertise ensures that data generated under the Australian Therapeutic Goods Administration (TGA) framework is accepted by the FDA and other major regulatory agencies worldwide.

In addition to regulatory speed and data quality, Australia offers a unique fiscal advantage with its 43.5% R&D tax rebate, significantly reducing early clinical trial costs — a major incentive for venture-backed biotech companies managing limited runway.

As part of its GlobalReady model, Avance Clinical also facilitates expansion into Asia, where its newly signed partnerships with leading Taiwanese and South Korean clinical sites offer biotechs access to large, treatment-naïve patient populations — essential for fast Phase II and III recruitment.

For later-phase trials, Avance Clinical also provides a seamless expansion to its US-based operational and regulatory teams, ensuring continuity, quality oversight, and alignment with sponsor expectations throughout the development lifecycle.

“Our model is built specifically for biotechs — agile, science-driven, capital efficient and globally integrated,” said Edwards. “From Australia to Asia to the US, we provide a single CRO partner to guide clinical programs from first-in-human to regulatory submission.”

Avance Clinical will be showcasing its GlobalReady capabilities at two major US conferences: the 2025 ASCO Annual Meeting in Chicago, 30 May – 3 June, and BIO International 2025 in Boston, 16 – 19 June. To schedule a meeting with the team, please visit www.avancecro.com.

About Avance Clinical

Avance Clinical is a leading full-service CRO offering biotech companies faster, more flexible, and higher-quality clinical trial services. Headquartered in Australia, Avance Clinical delivers globally accepted data across Australia, New Zealand, Asia, North America, and Europe. With over 30 years of experience and expertise in more than 250 indications, the company specializes in early to late-phase clinical trials, providing comprehensive support from pre-clinical consulting through to Phase I-II studies.

  • Discover Avance Clinical’s Australian Advantage and Asia Advantage
  • Get into clinic faster with Avance Clinical’s ClinicReady service
  • Learn about Avance Clinical’s GlobalReady model for biotechs
  • Speak with our scientific experts about your upcoming study
  • Book a meeting or request a proposal

For media enquiries, email media@avancecro.com.

You Might Also Like

Long-Term Follow-Up Data Continue to Support Beti-Cel as a Potentially Curative Gene Therapy for -Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels

Identity.com launches mobile app: A secure way to manage your digital ID

Kapsch TrafficCom satellite tolling addresses global traffic and environmental challenges

National Bank of Coxsackie staff volunteer at Regional Food Bank

Shri Amit Shah inaugurates Falcon Agrifriz’s state-of-the-art frozen potato products manufacturing facility in Kadi, Mehsana, Gujarat

TAGGED:acceptedadelaideaustraliaavancebiotechbiotechscapitalclinicaldataearlyphaseframeworkglobalreadyglobegrowsincreasinglyindlookingmayneednewswirephasepredictableregulatorysponsorsstablestatestrialsuncertaintyunitedwithout

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.

By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share This Article
Facebook Twitter Copy Link Print
Share
Previous Article MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
Next Article Transactions in Connection with Share Buy-back Program Transactions in Connection with Share Buy-back Program

Stay Connected

FacebookLike
TwitterFollow
PinterestPin
InstagramFollow
YoutubeSubscribe
Google NewsFollow
LinkedInFollow
MediumFollow
- Advertisement -

Latest News

MEXC Hits 40M Users with 46% Growth in New Listing Token Trading Volume in May
MEXC Hits 40M Users with 46% Growth in New Listing Token Trading Volume in May
Business 09/06/2025
BingX and Chelsea FC Unveil 25/26 Training Kit with “Trained on Greatness” Campaign
BingX and Chelsea FC Unveil 25/26 Training Kit with “Trained on Greatness” Campaign
Business 09/06/2025
Quantel Asset Management and Sincere Syndication Announce Strategic Partnership to Unlock U.S.-India Cross-Border Investment Opportunities
Quantel Asset Management and Sincere Syndication Announce Strategic Partnership to Unlock U.S.-India Cross-Border Investment Opportunities
Business 09/06/2025
$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed
$ZEUS Announces the Next Era: Trademark Secured, Artist Doxxed, Legacy Unleashed
Tech 09/06/2025
//

We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.

Quick Link

  • About Us
  • Contact Us
  • Editorial Guidelines
  • Privacy Policy
  • Terms and Conditions

Top Categories

  • Automobile
  • Education
  • Entertainment
  • Health
  • News
  • Sports
  • Tech

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

Life Care NewsLife Care News
Follow US
Copyright © 2015 - 2024 LifeCareNews Network. All Rights Reserved. LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?